Acadia Pharmaceuticals reported $6.33M in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acadia Pharmaceuticals ACAD:US $ 6.33M 0.68M
ALKERMES ALKS:US $ 155.61M 0.82M
Alnylam Pharmaceuticals ALNY:US $ 88.98M 10.46M
Biogen BIIB:US $ 1294.2M 78.8M
Biomarin Pharmaceutical BMRN:US $ 802.32M 15.96M
Bristol Myers Squibb BMY:US $ 2142M 38M
Cara Therapeutics CARA:US 3.46M 1.55M
Corcept Therapeutics CORT:US $ 17.42M 12.34M
Eisai 4523:JP Y 103510M 4502M
Eli Lilly And LLY:US $ 3899.4M 6.4M
Moderna Inc MRNA:US 1.92B 21M
Neurocrine Biosciences NBIX:US $ 29.3M 0.3M
Ptc Therapeutics PTCT:US $ 15M 0.28M
Sarepta Therapeutics SRPT:US $ 208.1M 9.1M
Seattle Genetics SGEN:US $ 319.35M 43.61M
Ultragenyx Pharmaceutical RARE:US $ 21.08M 3.27M
Vanda Pharmaceuticals VNDA:US 1.5M 206K
Vertex Pharmaceuticals VRTX:US $ 367.7M 28.8M
YTE INCY:US $ 54.5M 19.05M